The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
Open accessAbstract
BACKGROUND: Methylxanthine therapy is commonly used for apnea of prematurity but in the absence of adequate data on its efficacy and safety. It is uncertain whether methylxanthines have long-term effects on neurodevelopment and growth. METHODS: We randomly assigned 2006 infants with birth weights of 500 to 1250 g to receive either caffeine or placebo until therapy for apnea of prematurity was no longer needed. The primary outcome was a composite of death, cerebral palsy, cognitive delay (defined as a Mental Development Index score of <85 on the Bayley Scales of Infant Development), deafness, or blindness at a corrected age of 18 to 21 months. RESULTS: Of the 937 infants assigned to caffeine for whom adequate data on the primary outcome were available, 377 (40.2%) died or survived with a neurodevelopmental disability, as compared with 431 of the 932 infants (46.2%) assigned to placebo for whom adequate data on the primary outcome were available (odds ratio adjusted for center, 0.77; 95% confidence interval [CI], 0.64 to 0.93; P=0.008). Treatment with caffeine as compared with placebo reduced the incidence of cerebral palsy (4.4% vs. 7.3%; adjusted odds ratio, 0.58; 95% CI, 0.39 to 0.87; P=0.009) and of cognitive delay (33.8% vs. 38.3%; adjusted odds ratio, 0.81; 95% CI, 0.66 to 0.99; P=0.04). The rates of death, deafness, and blindness and the mean percentiles for height, weight, and head circumference at follow-up did not differ significantly between the two groups. CONCLUSIONS: Caffeine therapy for apnea of prematurity improves the rate of survival without neurodevelopmental disability at 18 to 21 months in infants with very low birth weight. (ClinicalTrials.gov number, NCT00182312 [ClinicalTrials.gov].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07414.x · Cited by 6,721
An Assessment of Clinically Useful Measures of the Consequences of Treatment
Laupacis, A., Sackett, D. L., & Roberts, R. S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182605 · Cited by 1,681
Self-citationThe Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
A New and Improved Population-Based Canadian Reference for Birth Weight for Gestational Age
Kramer, M. S., Platt, R. W., Wen, S. W., Joseph, K. S., Allen, A., Abrahamowicz, M., Blondel, B., Bréart, G., & for the Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System (2001) · Pediatrics · doi:10.1542/peds.108.2.e35 · Cited by 1,524
Manual for the Bayley Scales of Infant Development
Bayley, N. (1969) · Medical Entomology and Zoology · Cited by 1,328
Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054065 · Cited by 1,208
Self-citationAn international classification of retinopathy of prematurity
(1985) · International Ophthalmology · doi:10.1007/bf00136454 · Cited by 1,005
Schmidt, B., Asztalos, E. V., Roberts, R. S., Robertson, C. M. T., Sauve, R. S., Whitfield, M. F., & for the Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators (2003) · JAMA · doi:10.1001/jama.289.9.1124 · Cited by 629
Self-citationHack, M., Taylor, H. G., Drotar, D., Schluchter, M., Cartar, L., Wilson-Costello, D., Klein, N., Friedman, H., Mercuri-Minich, N., & Morrow, M. (2005) · Pediatrics · doi:10.1542/peds.2005-0173 · Cited by 605
Adenosine, Adenosine Receptors and the Actions of Caffeine
Fredholm, B. B. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00111.x · Cited by 597
Mechanisms of cell survival in hypoxia and hypothermia
Boutilier, R. G. (2001) · Journal of Experimental Biology · doi:10.1242/jeb.204.18.3171 · Cited by 519
Aaberg, T. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060070042025 · Cited by 476
Reported Medication Use in the Neonatal Intensive Care Unit: Data From a Large National Data Set
Clark, R. H., Bloom, B. T., Spitzer, A. R., & Gerstmann, D. R. (2006) · Pediatrics · doi:10.1542/peds.2005-1707 · Cited by 416
An International Classification of Retinopathy of Prematurity
(1984) · Pediatrics · doi:10.1542/peds.74.1.127 · Cited by 309
Efficacy of caffeine in treatment of apnea in the low-birth-weight infant
Aranda, J. V., Gorman, W., Bergsteinsson, H., & Gunn, T. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80718-x · Cited by 266
Methylxanthine treatment for apnea in preterm infants
Henderson-Smart, D. J., & Steer, P. A. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000140 · Cited by 254
Summary Proceedings From the Apnea-of-Prematurity Group
Finer, N. N., Higgins, R., Kattwinkel, J., & Martin, R. J. (2006) · Pediatrics · doi:10.1542/peds.2005-0620h · Cited by 196
Minimising ventilator induced lung injury in preterm infants
Donn, S. M. (2005) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2005.082271 · Cited by 100
Preterm outcomes research: a critical component of neonatal intensive care.
Allen, M. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10044 · Cited by 97
Controversies surrounding xanthine therapy
Millar, D., & Schmidt, B. K. (2004) · Seminars in Neonatology · doi:10.1016/j.siny.2003.11.008 · Cited by 77
Self-citationNeonatal Apnea: Diagnosis by Nurse Versus Computer
Muttitt, S. C., Finer, N. N., Tierney, A. J., & Rossmann, J. (1988) · PEDIATRICS · doi:10.1542/peds.82.5.713 · Cited by 71
Methylxanthine therapy in premature infants: Sound practice, disaster, or fruitless byway?
Schmidt, B. K. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70180-0 · Cited by 70
Self-citationSchmidt, B. K. (2005) · Neonatology · doi:10.1159/000087584 · Cited by 60
Self-citationCaffeine for Apnea of Prematurity
Bancalari, E. H. (2006) · New England Journal of Medicine · doi:10.1056/nejme068028 · Cited by 43
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
Thébaud, B., Goss, K. N., Laughon, M., Whitsett, J. A., Abman, S. H., Steinhorn, R. H., Aschner, J. L., Davis, P. G., McGrath-Morrow, S. A., Soll, R. F., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0127-7 · Cited by 1,070
Self-citationBronchopulmonary Dysplasia: Executive Summary of a Workshop
Higgins, R. D., Jobe, A. H., Koso-Thomas, M., Bancalari, E., Viscardi, R. M., Hartert, T. V., Ryan, R. M., Kallapur, S. G., Steinhorn, R. H., Konduri, G. G., et al. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.01.043 · Cited by 956
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Metadata
- Authors
- Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-11-08
- Volume
- 357
- Issue
- 19
- Pages
- 1893-1902
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130249957
- Cited by
- 948
- References
- 24
- FWCI
- 33.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.